Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
#:"(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)"
journalStr:"Nature communications"
topic_facet:"Antibodies, Viral"
(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=%23%3A%22%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29%22&filter%5B%5D=journalStr%3A%22Nature+communications%22&filter%5B%5D=topic_facet%3A%22Antibodies%2C+Viral%22&lookfor=%22antibodies%22&type=Subject
/vufind/Search/Results?filter%5B%5D=%23%3A%22%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29%22&filter%5B%5D=journalStr%3A%22Nature+communications%22&filter%5B%5D=topic_facet%3A%22Antibodies%2C+Viral%22&lookfor=%22antibodies%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=%23%3A%22%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29%22&filter%5B%5D=journalStr%3A%22Nature+communications%22&filter%5B%5D=topic_facet%3A%22Antibodies%2C+Viral%22&lookfor=%22antibodies%22&type=Subject
PubPharm (324)
1
Adjuvant-dependent impact of inactivated SARS-CoV-2 vaccines during heterologous infection by a SARS-related coronavirus
enthalten in:
Nature communications
| 2024
von
Dillard, J.
|
Taft-Benz, S.
|
Knight, A.
| +28
Wird geladen...
2
The hinge-engineered IgG1-IgG3 hybrid subclass IgGh47 potently enhances Fc-mediated function of anti-streptococcal and SARS-CoV-2 antibodies
enthalten in:
Nature communications
| 2024
von
Izadi, A.
|
Karami, Y.
|
Bratanis, E.
| +18
Wird geladen...
3
Mucosal prime-boost immunization with live murine pneumonia virus-vectored SARS-CoV-2 vaccine is protective in macaques
enthalten in:
Nature communications
| 2024
von
Kaiser, J.
|
Nelson, C.
|
Liu, X.
| +24
UpdateOf: Res Sq. 2023 Sep 13;:. - PMID 37790295
Wird geladen...
4
Long-term monitoring of SARS-CoV-2 seroprevalence and variants in Ethiopia provides prediction for immunity and cross-immunity
enthalten in:
Nature communications
| 2024
von
Merkt, S.
|
Ali, S.
|
Gudina, E.
| +21
Wird geladen...
5
An ancestral SARS-CoV-2 vaccine induces anti-Omicron variants antibodies by hypermutation
enthalten in:
Nature communications
| 2024
von
Park, S.
|
Choi, J.
|
Lee, Y.
| +14
Wird geladen...
6
Improvement of immune dysregulation in individuals with long COVID at 24-months following SARS-CoV-2 infection
enthalten in:
Nature communications
| 2024
von
Phetsouphanh, C.
|
Jacka, B.
|
Ballouz, S.
| +19
Wird geladen...
7
Emerging variants develop total escape from potent monoclonal antibodies induced by BA.4/5 infection
enthalten in:
Nature communications
| 2024
von
Liu, C.
|
Das, R.
|
Dijokaite-Guraliuc, A.
| +17
Wird geladen...
8
Vaccination impairs de novo immune response to omicron breakthrough infection, a precondition for the original antigenic sin
enthalten in:
Nature communications
| 2024
von
Pušnik, J.
|
Zorn, J.
|
Monzon-Posadas, W.
| +4
Wird geladen...
9
SARS-CoV-2-specific cellular and humoral immunity after bivalent BA.4/5 COVID-19-vaccination in previously infected and non-infected individuals
enthalten in:
Nature communications
| 2024
von
Urschel, R.
|
Bronder, S.
|
Klemis, V.
| +13
Wird geladen...
10
The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86
enthalten in:
Nature communications
| 2024
von
Zhou, D.
|
Supasa, P.
|
Liu, C.
| +14
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[33]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Filter aufheben
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Zeitschrift: Nature communications
Filter aufheben
Thema: Antibodies, Viral
Medienart
324
Aufsätze
324
E-Artikel
324
E-Ressourcen
Zeitschriftentitel
Nature communications
Thema
Antibodies, Viral
324
Journal Article
268
Research Support, Non-U.S. Gov't
205
Antibodies, Neutralizing
160
Spike Glycoprotein, Coronavirus
138
spike protein, SARS-CoV-2
103
COVID-19 Vaccines
86
Research Support, N.I.H., Extramural
74
Immunoglobulin G
45
Antibodies, Monoclonal
38
BNT162 Vaccine
30
Epitopes
27
Angiotensin-Converting Enzyme 2
27
EC 3.4.17.23
25
Viral Vaccines
23
N38TVC63NU
21
Vaccines, Synthetic
20
ACE2 protein, human
20
Research Support, U.S. Gov't, Non-P.H.S.
19
Immunoglobulin M
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
323
2020-
1
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
324
Englisch
Haven't found what you're looking for?
Wird geladen...